Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset - Nature Communications
www.nature.com
Parkinson’s disease is lacking easily accessible biomarkers. Here the authors show, that targeted blood proteomics is feasible to identify the patients and to predict the phenoconvertion in prodromal subjects up to 7 years before symptom onset.
  • AFK BRB Chocolate@lemmy.worldEnglish
    9·
    4 months ago

    If I’m understanding this right, they used a machine learning algorithm to identify some markers in the blood of Parkinson’s patients, and now they’re testing for those markers. The AI in question is ML, and isn’t involved in the actual testing.

  • JimSamtanko@lemm.eeEnglish
    3·
    4 months ago

    Meanwhile, we’re finding out that many of the hotshot AI breakthroughs were oversold. Hopefully this is not going to be another disaster.